In a significant move towards advancing healthcare services, Bengaluru-based Sparsh Hospitals has inked a Memorandum of Understanding (MOU) with GE Healthcare, marking a pivotal collaboration in the realm of precision medicine. The partnership aims to pioneer the development and validation of cutting-edge Artificial Intelligence (AI) and digital technologies, with a focus on enhancing care in critical areas such as oncology, cardiology, and neurology.
Similarly, Dr H Marzoeki Mahdi Hospital Bogor, Indonesia’s national referral center for mental health services, has recently entered into an MOU with King’s College Hospital in London, United Kingdom. The agreement aims to establish a perinatal mental health center in response to alarming statistics indicating that up to 57% of Indonesian mothers experienced “baby blues” or mild depression post-childbirth in the previous year, as reported by Indonesia’s National Population and Family Planning Board.
Drawing inspiration from King’s College Hospital’s Mother Baby Unit, the upcoming mental health facility at Marzoeki Mahdi Hospital will specialize in providing mental health services for pregnant women. The unit will implement Electronic Medical Records (EMRs) to introduce a digitized patient records system, ensuring the secure handling of sensitive mental health-related data, as stated by Marzoeki Mahdi Hospital director, Dr Nova Riyanti Yusuf.
In a bid to enhance its capabilities in arrhythmia detection, Kokilaben Dhirubhai Ambani Hospital in Mumbai has partnered with Swiss medical device company SmartCardia. The tertiary hospital is set to implement the AI-powered SmartCardia 7L (seven-lead) patch, which facilitates the near-real-time transmission of Electrocardiogram (ECG) and other vital signs to the cloud. This technology enables immediate access to patient data for healthcare providers and automatic alerts for critical events, ultimately aiding in swift and proactive patient care.
Meanwhile, the Apollo Proton Cancer Centre has launched the Apollo Rectal Cancer Programme, incorporating robotic surgery as a pivotal element. Serving as India’s exclusive center for rectal cancer, the program emphasizes comprehensive and multidisciplinary care with a focus on rectal preservation. Among the range of treatments offered, robotic surgery stands out for its ability to address persistent diseases, removing residual tumors and employing advanced robotic surgical techniques to avoid permanent colostomy or the use of a permanent bag, as explained by APCC colorectal consultant and robotic surgeon Dr. Venkatesh Munikrishnan. The center also provides chemoradiotherapy and proton therapy, making it a hub for organ-specific cancer care.
